BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 7940694)

  • 1. Antibody-mediated rejection of an HLA-identical, ABO-incompatible kidney transplant after two failed cadaver transplants.
    Fryer JP; Benedetti E; Perry EH; Matas AJ
    Transplantation; 1994 Sep; 58(6):723-5. PubMed ID: 7940694
    [No Abstract]   [Full Text] [Related]  

  • 2. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
    Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
    Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation.
    Toki D; Ishida H; Horita S; Yamaguchi Y; Tanabe K
    Transplantation; 2009 Nov; 88(10):1186-93. PubMed ID: 19935372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful living donor kidney transplantation across HLA and ABO incompatibilities.
    Magee CC; Mah H; Tinckam K; Wood I; Ji F; Powelson J
    Nephrol Dial Transplant; 2007 Feb; 22(2):602-4. PubMed ID: 17132704
    [No Abstract]   [Full Text] [Related]  

  • 5. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
    Ashimine S; Watarai Y; Yamamoto T; Hiramitsu T; Tsujita M; Nanmoku K; Goto N; Takeda A; Katayama A; Uchida K; Kobayashi T
    Kidney Int; 2014 Feb; 85(2):425-30. PubMed ID: 23945498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of acute antibody-mediated rejection in ABO-incompatible kidney transplantation: which anti-A/anti-B antibodies are responsible, natural or de novo?
    Takahashi K; Saito K; Nakagawa Y; Tasaki M; Hara N; Imai N
    Transplantation; 2010 Mar; 89(5):635-7. PubMed ID: 20216373
    [No Abstract]   [Full Text] [Related]  

  • 7. Accommodation: does it apply to human leukocyte antigens?
    Rose ML; West LJ
    Transplantation; 2012 Feb; 93(3):244-6. PubMed ID: 22167050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological analysis of rejection episodes in ABO-incompatible kidney transplantation.
    Tanabe K; Takahashi K; Sonda K; Onituka S; Yamaguchi Y; Agishi T; Koga S; Koga T; Nakazawa H; Goya N; Yagisawa T; Fuchinoue S; Kawai T; Toma H; Ota K
    Transplant Proc; 1996 Jun; 28(3):1447-8. PubMed ID: 8658734
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of HLA-identity on results of ABO-incompatible living kidney transplantation.
    Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Teraoka S; Toma H
    Transplant Proc; 2004 Sep; 36(7):2172-4. PubMed ID: 15518790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.
    Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N
    Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.
    Collins AB; Chicano SL; Cornell LD; Tolkoff-Rubin N; Goes NB; Saidman SL; Farrell ML; Cosimi AB; Colvin RB
    Transplant Proc; 2006 Dec; 38(10):3427-9. PubMed ID: 17175293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of tissue typing in corneal transplantation.
    Allansmith MR; Drell D; Kajiyama G; Fine M
    Mod Probl Ophthalmol; 1976; 16():167-74. PubMed ID: 765781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation across previously incompatible immunological barriers.
    Magee CC
    Transpl Int; 2006 Feb; 19(2):87-97. PubMed ID: 16441356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present status of ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Saito K
    Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: Eculizumab rescue of severe accelerated antibody-mediated rejection after ABO-incompatible kidney transplant.
    Stewart ZA; Collins TE; Schlueter AJ; Raife TI; Holanda DG; Nair R; Reed AI; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3033-6. PubMed ID: 23195021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming immunologic incompatibility: transplanting the difficult to transplant patient.
    Crew RJ; Ratner LE
    Semin Dial; 2005; 18(6):474-81. PubMed ID: 16398709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients.
    Sharif A; Alachkar N; Bagnasco S; Geetha D; Gupta G; Womer K; Arend L; Racusen L; Montgomery R; Kraus E
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1320-7. PubMed ID: 22626962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial chimerism after ABO-incompatible kidney transplantation.
    Tanabe T; Ishida H; Horita S; Honda K; Yamaguchi Y; Nonomura K; Tanabe K
    Transplantation; 2012 Apr; 93(7):709-16. PubMed ID: 22456486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.